Catherine L Clelland

Title: The Innovative Contributions of Catherine L Clelland

Introduction

Catherine L Clelland is a notable inventor based in New York, NY, who has made significant contributions to the field of mental health through her innovative patents. With a total of six patents to her name, she has focused on developing methods that enhance treatment options for disorders such as schizophrenia and bipolar disorder.

Latest Patents

Among her latest patents is a method for predicting a subject's response to SLC modulator therapy. This invention provides methods for treating or ameliorating the effects of disorders by increasing or decreasing proline levels. Additionally, it includes methods for predicting and monitoring clinical responses in patients, as well as diagnostic systems for identifying individuals likely to benefit from proline modulation. Another significant patent is for predicting a subject's response to valproic acid therapy, which similarly addresses the treatment of mental health disorders through proline modulation.

Career Highlights

Catherine has worked with esteemed organizations such as the Research Foundation for Mental Hygiene, Inc. and Columbia University. Her work in these institutions has allowed her to contribute to important research and development in the field of mental health.

Collaborations

Catherine has collaborated with notable individuals in her field, including James D Clelland and Frank Carter Bancroft. These collaborations have likely enriched her research and innovation efforts.

Conclusion

Catherine L Clelland's work exemplifies the impact of innovative thinking in the realm of mental health treatment. Her patents not only advance scientific understanding but also offer hope for improved therapeutic strategies for individuals facing mental health challenges.